10-Q | 2020-11-30 | Filed 2021-01-19 |
10-Q | 2020-08-31 | Filed 2020-10-15 |
10-Q | 2020-05-31 | Filed 2020-07-13 |
10-K | 2020-02-29 | Filed 2020-05-29 |
10-Q | 2019-11-30 | Filed 2020-01-13 |
10-Q | 2019-08-31 | Filed 2019-10-15 |
10-Q | 2019-05-31 | Filed 2019-07-19 |
10-K | 2019-02-28 | Filed 2019-06-13 |
10-Q | 2018-11-30 | Filed 2019-01-17 |
10-Q | 2018-08-31 | Filed 2018-10-15 |
10-Q | 2018-05-31 | Filed 2018-07-16 |
10-K | 2018-02-28 | Filed 2018-06-13 |
10-Q | 2017-11-30 | Filed 2018-01-18 |
10-Q | 2017-08-31 | Filed 2017-10-23 |
10-Q | 2017-05-31 | Filed 2017-07-14 |
10-K | 2017-02-28 | Filed 2017-05-08 |
10-Q | 2016-11-30 | Filed 2017-01-23 |
10-Q | 2016-08-31 | Filed 2016-10-18 |
10-Q | 2016-05-31 | Filed 2016-07-20 |
10-K | 2016-02-29 | Filed 2016-06-23 |
10-Q | 2015-11-30 | Filed 2016-01-19 |
10-Q | 2015-08-31 | Filed 2015-10-16 |
10-Q | 2015-05-31 | Filed 2015-08-07 |
10-K | 2015-02-28 | Filed 2015-06-16 |
10-Q | 2014-11-30 | Filed 2015-01-20 |
10-Q | 2014-08-31 | Filed 2014-10-20 |
10-Q | 2014-05-31 | Filed 2014-07-21 |
10-K | 2014-02-28 | Filed 2014-06-13 |
10-Q | 2013-11-30 | Filed 2014-01-21 |
10-Q | 2013-08-31 | Filed 2013-10-21 |
10-K | 2013-02-28 | Filed 2013-06-13 |
10-Q | 2012-11-30 | Filed 2013-01-22 |
10-Q | 2012-08-31 | Filed 2012-10-22 |
10-Q | 2012-05-31 | Filed 2012-07-23 |
10-K | 2012-02-29 | Filed 2012-06-13 |
10-Q | 2011-11-30 | Filed 2012-01-23 |
10-Q | 2011-08-31 | Filed 2011-10-21 |
10-Q | 2011-05-31 | Filed 2011-07-19 |
10-K | 2011-02-28 | Filed 2011-06-15 |
10-Q | 2010-11-30 | Filed 2011-01-13 |
10-Q | 2010-08-31 | Filed 2010-10-21 |
10-Q | 2010-05-31 | Filed 2010-07-15 |
10-K | 2010-02-28 | Filed 2010-06-08 |
10-Q | 2009-11-30 | Filed 2010-01-19 |
Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546 | 323 | 0 | 0 | 0 | 0 | -854 | |||
1 800 Flowers Com (FLWS) | 944 | 42% | 13.3 | 6% | 665 | 336 | 1,266 | 534 | 37 | 75 | 1,001 |
10x Genomics (TXG) | 4,805 | 75% | -490.3 | -2% | 573 | 151 | 61 | 46 | -10 | -9 | 4,357 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1 | 20 | 1 | 0 | -15 | -15 | 1 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 34 | 0% | 0.4 | -5% | 164 | 108 | 18 | 0 | -8 | -8 | -3 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 19 | 23 | 27 | 7 | -3 | -1 | 3 | |
1895 Bancorp of Wisconsin (BCOW) | 46,153 | 12,508.1 | -0% | 441 | 383 | 0 | 0 | -0 | 4 | 46,142 | |
1st Constitution Bancorp (FCCY) | 165 | 0% | 4.4 | 1% | 1,343 | 1,204 | 0 | 0 | 14 | 33 | 144 |
1st Franklin Financial (FFC) | 4 | -0.6 | 7% | 905 | 645 | 0 | 0 | 62 | 80 | -46 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200 | 7.9 | 1% | 6,691 | 5,858 | 0 | 0 | 70 | 136 | 1,073 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 2 | 0 | 0 | -2 | -2 | 0 | |
21Vianet Group (VNET) | 6,005 | 0% | 11,151 | 5,788 | 0 | 0 | 0 | 0 | 3,344 | ||
22nd Century (XXII) | 302 | 1% | -14.1 | -36% | 62 | 7 | 26 | 0 | -22 | -21 | 302 |
1Life Healthcare (ONEM) |
Balance Sheet ($MM) | 2011-11-30 | 2012-02-29 | 2012-05-31 | 2012-08-31 | 2012-11-30 | 2013-08-31 | 2014-02-28 | 2014-05-31 | 2014-08-31 | 2014-11-30 | 2015-02-28 | 2015-05-31 | 2015-08-31 | 2015-11-30 | 2016-02-29 | 2016-05-31 | 2016-08-31 | 2016-11-30 | 2017-02-28 | 2017-05-31 | 2017-08-31 | 2017-11-30 | 2018-02-28 | 2018-05-31 | 2018-08-31 | 2018-11-30 | 2019-02-28 | 2019-05-31 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||
Inventory | ||||||||||||||||||||||||||||
PP&E | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||
Assets | 3 | 0 | 1 | 1 | 5 | 5 | 5 | 5 | 4 | 4 | 7 | 7 | 7 | 7 | 3 | 2 | 3 | 3 | 3 | 2 | 7 | 9 | 6 | 7 | 7 | 7 | 10 | 11 |
Accounts Payable | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | |||||||||||||||||
Long-Term Debt | 0 | 0 | 7 | 8 | 7 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||
Liabilities | 13 | 15 | 15 | 13 | 15 | 17 | 14 | 13 | 13 | 14 | 13 | 10 | 10 | 10 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 2 | 2 | 2 | 2 |
Stockholders' Equity | -10 | -14 | -14 | -12 | -10 | -15 | -14 | -14 | -14 | -18 | -6 | -3 | -3 | -3 | -1 | -1 | -1 | -0 | -0 | |||||||||
Income Statement ($MM) | 2011-11-30 | 2012-02-29 | 2012-05-31 | 2012-08-31 | 2012-11-30 | 2013-08-31 | 2014-02-28 | 2014-05-31 | 2014-08-31 | 2014-11-30 | 2015-02-28 | 2015-05-31 | 2015-08-31 | 2015-11-30 | 2016-02-29 | 2016-05-31 | 2016-08-31 | 2016-11-30 | 2017-02-28 | 2017-05-31 | 2017-08-31 | 2017-11-30 | 2018-02-28 | 2018-05-31 | 2018-08-31 | 2018-11-30 | 2019-02-28 | 2019-05-31 |
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cost of Revenue | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Gross Profit | -0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | |
R&D | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||
SG&A | 2 | 3 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 2 | 0 | 1 | 0 | 2 | 1 | 0 | 1 | 1 | 0 | |
Tax | ||||||||||||||||||||||||||||
Net Income | -3 | -6 | -1 | -0 | -2 | -5 | -0 | -1 | -1 | 5 | 1 | -1 | -5 | 4 | -1 | -1 | -2 | -3 | -1 | -0 | -2 | -6 | -1 | 5 | -2 | 2 | -1 | |
Cash Flow ($MM) | 2011-11-30 | 2012-02-29 | 2012-05-31 | 2012-08-31 | 2012-11-30 | 2013-08-31 | 2014-02-28 | 2014-05-31 | 2014-08-31 | 2014-11-30 | 2015-02-28 | 2015-05-31 | 2015-08-31 | 2015-11-30 | 2016-02-29 | 2016-05-31 | 2016-08-31 | 2016-11-30 | 2017-02-28 | 2017-05-31 | 2017-08-31 | 2017-11-30 | 2018-02-28 | 2018-05-31 | 2018-08-31 | 2018-11-30 | 2019-02-28 | 2019-05-31 |
Cash Operating | -1 | -1 | -1 | -2 | 1 | -1 | -1 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||||
Cash Investing | -0 | -0 | 0 | 0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | 0 | -0 | |||||||
Cash Financing | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 2 | 1 | 2 | 0 | -0 | 2 | 0 | 1 | 0 | 2 |